Breast Cancer Clinical Trials in Los Angeles

Showing 241-260 of 302 trials

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

NCT00398567

The purpose of this study is to determine the safety and efficacy of HKI-272 (neratinib) in combination with trastuzumab in patients with advanced breast cancer.

Advanced Breast Cancer

Puma Biotechnology, Inc.45 participantsStarted Apr 2007

Duarte, California, United States • Los Angeles, California, United States • Pasadena, California, United States +11 more locations

COMPLETEDNA< 1 mile

Digital Mammography Screening Trial (ACRIN6652)

NCT00008346

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for cancer. It is not yet known which type of mammography is more effective in detecting breast cancer. PURPOSE: Screening and diagnostic trial to compare the effectiveness of two types of mammography in detecting breast cancer in women.

Breast Cancer

American College of Radiology Imaging Network49,528 participantsStarted Oct 2001

Los Angeles, California, United States • Sacramento, California, United States • Aurora, Colorado, United States +29 more locations

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Digital Mammography Screening Trial (ACRIN6652)

Breast Cancer Trials in Other Cities

Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

NOLAN: Naproxen or Loratadine and Neulasta

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.

Ixabepilone + Carboplatin Metastatic Breast Cancer

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

Other Conditions in Los Angeles